Table of Contents
Introduction
-
- Definition
- Methodology
- Consumer research
- Abbreviations
Executive Summary
-
- The market
-
- Figure 1: Best- and worst-case scenario for UK retail value sales of gastrointestinal remedies, 2008-18
- Level of new product development falling
-
- Figure 2: New product launches, by branded vs. own-label, 2009-13
- Companies, brands and innovation
-
- Figure 3: UK retail value sales of gastrointestinal remedies, by brand, year ending August 2013
- The consumer
-
- Figure 4: Gastrointestinal ailments suffered in last 12 months and treatments, September 2013
- Figure 5: Selected attitudes towards treatment of gastrointestinal ailments, September 2013
-
- Figure 6: Selected attitudes towards buying gastrointestinal remedies, September 2013
- What we think
Issues in the Market
-
- What role does own-label have in this category?
- Why are people reluctant to take gastrointestinal remedies?
- What are the opportunities for new innovations?
- How will growth of the over-65s impact the category?
Trend Applications
-
- Trend: Transumers
- Trend: Extend My Brand
- Mintel Futures: East Meets West
Market Drivers
-
- Key points
- Young urban professionals are a target group
-
- Figure 7: Trends in the age structure of the UK population, 2008-18
- The over-65s set to remain fastest-growing age group
- Socio-economic groups – opportunities for industry growth
-
- Figure 8: Forecast adult population trends, by socio-economic group, 2008-18
- Consumers prioritise exercise over healthy eating
-
- Figure 9: Factors important for a healthy lifestyle, November 2012
- Gastrointestinal remedies and the NHS
-
- Figure 10: Number of gastrointestinal prescription items dispensed, 2009-12
- Gradual increase in foreign travel increases market options
-
- Figure 11: UK residents’ visits abroad, by month, 2011-13
Who’s Innovating?
-
- Key points
- Own-label launches show decline
-
- Figure 12: New product launches, by branded vs. own-label, 2009-13
-
- Figure 13: Examples of own-label launches, January-September 2013
- Alternative formats increase in 2013
-
- Figure 14: New product activity in gastrointestinal remedies, by format, 2009-13
- Figure 15: Examples of alternative format launches, January-September 2013
- Rise in time/speed claims
-
- Figure 16: New product activity in gastrointestinal remedies, % share by leading claims, 2009-13
- Figure 17: Examples of products with time/speed claims, January-September 2013
- Majority of product launches flavourless
-
- Figure 18: New product activity in gastrointestinal remedies, % share by leading flavours, 2009-13
Market Size and Forecast
-
- Key points
- Historical decline in value
-
- Figure 19: UK retail value sales of gastrointestinal remedies, at current and constant prices, 2008-18
- Rise in value predicted for the future
-
- Figure 20: Best- and worst-case scenario for UK retail value sales of gastrointestinal remedies, 2008-18
- Forecast methodology
Segment Performance
-
- Key points
- Rise in price per unit drives growth of diarrhoea treatments
-
- Figure 21: UK retail value sales of gastrointestinal remedies, by segment, 2012 and 2013
Market Share
-
- Key points
- 2013 is the year of the brands
-
- Figure 22: UK retail value sales of gastrointestinal remedies, by brand, years ending August 2012 and August 2013
- Gaviscon Double Action grows in value
-
- Figure 23: UK retail value sales of indigestion remedies, by brand, years ending August 2012 and August 2013
- Imodium remains the leader in anti-diarrhoeals
-
- Figure 24: UK retail value sales of anti-diarrhoeals, by brand, years ending August 2012 and August 2013
- Laxatives
-
- Figure 25: UK retail value sales of laxatives, by brand, years ending August 2012 and August 2013
Companies and Products
-
- Bayer Healthcare
-
- Figure 26: Financial performance of Bayer Healthcare UK & Ireland, 2011 and 2012
-
- Figure 27: New product launches by Bayer, December 2012-August 2013
- Reckitt Benckiser Group plc
-
- Figure 28: Financial performance of Reckitt Benckiser, 2011 and 2012
-
- Figure 29: New product launches by Reckitt Benckiser, December 2012-August 2013
- Boehringer Ingelheim
-
- Figure 30: Financial performance of Boehringer Ingelheim Ltd., 2011 and 2012
-
- Figure 31: New product launches by Boehringer Ingelheim, December 2012-August 2013
- GlaxoSmithKline
-
- Figure 32: Financial performance of GlaxoSmithKline, 2011 and 2012
-
- Figure 33: New product launches by GlaxoSmithKline, December 2012-August 2013
- Alliance Boots
-
- Figure 34: Financial performance of Alliance Boots, 2012 and 2013
-
- Figure 35: New product launches by Alliance Boots, December 2012-August 2013
Brand Communication and Promotion
-
- Key points
- Advertising spend peaked in 2011
-
- Figure 36: Main media advertising expenditure of gastrointestinal remedies, 2009-13
- Reckitt Benckiser continues to dominate advertising expenditure
-
- Figure 37: Main media advertising expenditure on gastrointestinal remedies, by the top advertisers, January-August 2013
- TV holds the majority of advertising spend
-
- Figure 38: Main media advertising expenditure on gastrointestinal remedies, by media type, 2011 and 2012
Channels to Market
-
- Key points
- Supermarkets offer convenient purchasing
-
- Figure 39: Estimated UK retail value sales of gastrointestinal remedies, by channel, 2012 and 2013
- Chemists and pharmacies appeal with in-store experts
The Consumer – Experience and Management of Gastrointestinal Complaints
-
- Key points
- Most people prefer to do nothing
-
- Figure 40: Gastrointestinal ailments suffered in last 12 months and treatments, September 2013
- Men are more likely to suffer from digestive health issues…
-
- Figure 41: Gender differences in treatment of any gastrointestinal ailment, September 2013
- …but women are more willing to take non-prescription remedies
- Younger people more likely to let symptoms run their course
- Lack of preparation when it comes to digestive health issues
-
- Figure 42: Selected attitudes towards treatment of gastrointestinal ailments, September 2013
- Men can be encouraged to take a more active approach to their digestive health
The Consumer – Purchasing of Gastrointestinal Remedies
-
- Key points
- Brand loyalty is high
-
- Figure 43: Attitudes towards buying gastrointestinal remedies, September 2013
- The holiday market
- Few people go to the pharmacist for advice
The Consumer – Interest in New Product Innovation
-
- Key points
- Preventative measures are of interest
-
- Figure 44: Interest in new product development, September 2013
- Products with benefits beyond digestive health
The Consumer – Attitudes towards Gastrointestinal Remedies/Issues
-
- Key points
- People are sceptical of gastrointestinal remedies
-
- Figure 45: Attitudes towards gastrointestinal remedies/issues, September 2013
- Young people are confused
- Gastrointestinal issues stir up emotions
Consumer Typologies
-
- Key points
-
- Figure 46: Target groups for gastrointestinal remedies, September 2013
- Remedy Ready – 40%
- Who are they?
- Diet Managers – 36%
- Who are they?
- Sceptics – 24%
- Who are they?
Appendix – Segment Performance
-
-
- Figure 47: UK retail volume sales of gastrointestinal remedies, by segment, 2012 and 2013
-
Appendix – The Consumer – Experience and Management of Gastrointestinal Complaints
-
-
- Figure 48: Gastrointestinal ailments suffered in last 12 months and treatments, September 2013
-
- Figure 49: Gastrointestinal ailments suffered in last 12 months and treatments – All gastrointestinal ailments, by demographics, September 2013
-
- Figure 50: Gastrointestinal ailments suffered in last 12 months and treatments – Heartburn, acid reflux or stomach ulcer, by demographics, September 2013
-
- Figure 51: Gastrointestinal ailments suffered in last 12 months and treatments – Indigestion, by demographics, September 2013
-
- Figure 52: Gastrointestinal ailments suffered in last 12 months and treatments – Diarrhoea, by demographics, September 2013
-
- Figure 53: Gastrointestinal ailments suffered in last 12 months and treatments – Constipation, by demographics, September 2013
-
- Figure 54: Gastrointestinal ailments suffered in last 12 months and treatments – Wind, bloating or flatulence, by demographics, September 2013
-
- Figure 55: Gastrointestinal ailments suffered in last 12 months and treatments – Stomach cramps, by demographics, September 2013
-
- Figure 56: Gastrointestinal ailments suffered in last 12 months and treatments – Motion sickness or nausea, by demographics, September 2013
-
- Figure 57: Gastrointestinal ailments suffered in last 12 months and treatments – Stress or nervous stomach, by demographics, September 2013
-
- Figure 58: Gastrointestinal ailments suffered in last 12 months and treatments – Irritable Bowel Syndrome, by demographics, September 2013
-
- Figure 59: Gastrointestinal ailments suffered in last 12 months and treatments – Stomach irritation from lactose intolerance, gluten intolerance or other food sensitivity, by demographics, September 2013
-
- Figure 60: Attitudes towards treating gastrointestinal ailments, September 2013
-
- Figure 61: Attitudes towards treating gastrointestinal ailments, by demographics, September 2013
-
- Figure 62: Attitudes towards treating gastrointestinal ailments, by demographics, September 2013 (continued)
-
Appendix – The Consumer – Purchasing of Gastrointestinal Remedies
-
-
- Figure 63: Attitudes towards buying gastrointestinal remedies, September 2013
-
- Figure 64: Attitudes towards buying gastrointestinal remedies, by demographics, September 2013
-
- Figure 65: Attitudes towards buying gastrointestinal remedies, by demographics, September 2013 (continued)
-
- Figure 66: Attitudes towards buying gastrointestinal remedies, by demographics, September 2013 (continued)
-
Appendix – The Consumer – Interest in New Product Innovation
-
-
- Figure 67: Interest in new product development, September 2013
-
- Figure 68: Interest in new product development – Snacks or drinks that aid digestive issues, by demographics, September 2013
-
- Figure 69: Interest in new product development – Remedies containing my daily dose of vitamins, by demographics, September 2013
-
- Figure 70: Interest in new product development – After-treatments to help prevent experiencing a gastrointestinal issue again, by demographics, September 2013
-
- Figure 71: Interest in new product development – Preventative remedies that I can take before experiencing a gastrointestinal issue, by demographics, September 2013
-
- Figure 72: Interest in new product development – A remedy to be taken before a meal to prepare the stomach, by demographics, September 2013
-
- Figure 73: Interest in new product development – Remedies/treatments that aid weight management as well as digestive issues, by demographics, September 2013
-
- Figure 74: Interest in new product development – Detoxifying treatments for the digestive system, by demographics, September 2013
-
- Figure 75: Interest in new product development – Apps to help identify foods that could be causing digestive issues, by demographics, September 2013
-
- Figure 76: Interest in new product development – A powder remedy to sprinkle on top of food, by demographics, September 2013
-
- Figure 77: Interest in new product development – Heat patches that can improve digestion, by demographics, September 2013
-
- Figure 78: Interest in new product development – Colonic/abdominal massaging, by demographics, September 2013
-
- Figure 79: Interest in new product development – Colon cleansing/colonic irrigation, by demographics, September 2013
-
- Figure 80: Interest in new product development, by ailments and treatments – All gastrointestinal ailments, September 2013
-
Appendix – The Consumer – Attitudes towards Gastrointestinal Remedies/Issues
-
-
- Figure 81: Attitudes towards gastrointestinal remedies/issues, September 2013
-
- Figure 82: Agreement with the statement ‘It’s difficult to know what causes gastrointestinal issues’, by demographics, September 2013
-
- Figure 83: Agreement with the statement ‘I get frustrated when gastrointestinal issues get in the way of things I want to do’, by demographics, September 2013
-
- Figure 84: Agreement with the statement ‘It is possible to manage gastrointestinal issues with diet alone’, by demographics, September 2013
-
- Figure 85: Agreement with the statement ‘It’s difficult to know which remedies are best suited for specific gastrointestinal issues’, by demographics, September 2013
-
- Figure 86: Agreement with the statement ‘It’s easy to become reliant on non-prescription gastrointestinal remedies’, by demographics, September 2013
-
- Figure 87: Agreement with the statement ‘It’s better to treat gastrointestinal issues with natural remedies’, by demographics, September 2013
-
- Figure 88: Agreement with the statement ‘Suffering from gastrointestinal issues makes me feel unattractive’, by demographics, September 2013
-
- Figure 89: Agreement with the statement ‘I am concerned about the side effects of non-prescription gastrointestinal remedies’, by demographics, September 2013
-
- Figure 90: Agreement with the statement ‘I feel embarrassed talking about gastrointestinal issues’, by demographics, September 2013
-
- Figure 91: Agreement with the statement ‘Suffering from gastrointestinal issues affects my social life’, by demographics, September 2013
-
- Figure 92: Agreement with the statement ‘Non-prescription gastrointestinal remedies are used to manage a bad diet’, by demographics, September 2013
-
- Figure 93: Attitudes towards gastrointestinal remedies/issues, by ailments and treatments – All gastrointestinal ailments, September 2013
-
Appendix – Consumer Typologies
-
-
- Figure 94: Target groups, September 2013
-
- Figure 95: Ailments and treatments, by target groups, September 2013
-
- Figure 96: Attitudes towards treating gastrointestinal ailments, by target groups, September 2013
-
- Figure 97: Interest in new product innovation, by target groups, September 2013
-
- Figure 98: Interest in new product development, by target groups, September 2013
-
- Figure 99: Attitudes towards gastrointestinal remedies/issues, by target groups, September 2013
-
Back to top